1 Age Related Macular Degeneration Drug Market Overview 1.1 Product Overview and Scope of Age Related Macular Degeneration Drug 1.2 Age Related Macular Degeneration Drug Segment by Type 1.2.1 Global Age Related Macular Degeneration Drug Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Lucentis 1.2.3 Eylea 1.2.4 Avastin 1.2.5 Other 1.3 Age Related Macular Degeneration Drug Segment by Application 1.3.1 Age Related Macular Degeneration Drug Sales Comparison by Application: (2021-2027) 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Other 1.4 Global Age Related Macular Degeneration Drug Market Size Estimates and Forecasts 1.4.1 Global Age Related Macular Degeneration Drug Revenue 2016-2027 1.4.2 Global Age Related Macular Degeneration Drug Sales 2016-2027 1.4.3 Age Related Macular Degeneration Drug Market Size by Region: 2016 Versus 2021 Versus 2027 2 Age Related Macular Degeneration Drug Market Competition by Manufacturers 2.1 Global Age Related Macular Degeneration Drug Sales Market Share by Manufacturers (2016-2021) 2.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Age Related Macular Degeneration Drug Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Age Related Macular Degeneration Drug Manufacturing Sites, Area Served, Product Type 2.5 Age Related Macular Degeneration Drug Market Competitive Situation and Trends 2.5.1 Age Related Macular Degeneration Drug Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Age Related Macular Degeneration Drug Players Market Share by Revenue 2.5.3 Global Age Related Macular Degeneration Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Age Related Macular Degeneration Drug Retrospective Market Scenario by Region 3.1 Global Age Related Macular Degeneration Drug Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Age Related Macular Degeneration Drug Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Age Related Macular Degeneration Drug Market Facts & Figures by Country 3.3.1 North America Age Related Macular Degeneration Drug Sales by Country 3.3.2 North America Age Related Macular Degeneration Drug Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Age Related Macular Degeneration Drug Market Facts & Figures by Country 3.4.1 Europe Age Related Macular Degeneration Drug Sales by Country 3.4.2 Europe Age Related Macular Degeneration Drug Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Age Related Macular Degeneration Drug Market Facts & Figures by Region 3.5.1 Asia Pacific Age Related Macular Degeneration Drug Sales by Region 3.5.2 Asia Pacific Age Related Macular Degeneration Drug Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Age Related Macular Degeneration Drug Market Facts & Figures by Country 3.6.1 Latin America Age Related Macular Degeneration Drug Sales by Country 3.6.2 Latin America Age Related Macular Degeneration Drug Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Age Related Macular Degeneration Drug Market Facts & Figures by Country 3.7.1 Middle East and Africa Age Related Macular Degeneration Drug Sales by Country 3.7.2 Middle East and Africa Age Related Macular Degeneration Drug Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Age Related Macular Degeneration Drug Historic Market Analysis by Type 4.1 Global Age Related Macular Degeneration Drug Sales Market Share by Type (2016-2021) 4.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Type (2016-2021) 4.3 Global Age Related Macular Degeneration Drug Price by Type (2016-2021) 5 Global Age Related Macular Degeneration Drug Historic Market Analysis by Application 5.1 Global Age Related Macular Degeneration Drug Sales Market Share by Application (2016-2021) 5.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Application (2016-2021) 5.3 Global Age Related Macular Degeneration Drug Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Regeneron Pharmaceuticals 6.1.1 Regeneron Pharmaceuticals Corporation Information 6.1.2 Regeneron Pharmaceuticals Description and Business Overview 6.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Regeneron Pharmaceuticals Product Portfolio 6.1.5 Regeneron Pharmaceuticals Recent Developments/Updates 6.2 Bayer HealthCare 6.2.1 Bayer HealthCare Corporation Information 6.2.2 Bayer HealthCare Description and Business Overview 6.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Bayer HealthCare Product Portfolio 6.2.5 Bayer HealthCare Recent Developments/Updates 6.3 Novartis 6.3.1 Novartis Corporation Information 6.3.2 Novartis Description and Business Overview 6.3.3 Novartis Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Novartis Product Portfolio 6.3.5 Novartis Recent Developments/Updates 6.4 Roche 6.4.1 Roche Corporation Information 6.4.2 Roche Description and Business Overview 6.4.3 Roche Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Roche Product Portfolio 6.4.5 Roche Recent Developments/Updates 6.5 Kanghong Pharma 6.5.1 Kanghong Pharma Corporation Information 6.5.2 Kanghong Pharma Description and Business Overview 6.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Kanghong Pharma Product Portfolio 6.5.5 Kanghong Pharma Recent Developments/Updates 7 Age Related Macular Degeneration Drug Manufacturing Cost Analysis 7.1 Age Related Macular Degeneration Drug Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug 7.4 Age Related Macular Degeneration Drug Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Age Related Macular Degeneration Drug Distributors List 8.3 Age Related Macular Degeneration Drug Customers 9 Age Related Macular Degeneration Drug Market Dynamics 9.1 Age Related Macular Degeneration Drug Industry Trends 9.2 Age Related Macular Degeneration Drug Growth Drivers 9.3 Age Related Macular Degeneration Drug Market Challenges 9.4 Age Related Macular Degeneration Drug Market Restraints 10 Global Market Forecast 10.1 Age Related Macular Degeneration Drug Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Age Related Macular Degeneration Drug by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Age Related Macular Degeneration Drug by Type (2022-2027) 10.2 Age Related Macular Degeneration Drug Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Age Related Macular Degeneration Drug by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Age Related Macular Degeneration Drug by Application (2022-2027) 10.3 Age Related Macular Degeneration Drug Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Age Related Macular Degeneration Drug by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Age Related Macular Degeneration Drug by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Age Related Macular Degeneration Drug Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Age Related Macular Degeneration Drug Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Age Related Macular Degeneration Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Age Related Macular Degeneration Drug Covered in This Study Table 5. Global Age Related Macular Degeneration Drug Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Age Related Macular Degeneration Drug Sales Share by Manufacturers (2016-2021) Table 7. Global Age Related Macular Degeneration Drug Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Age Related Macular Degeneration Drug Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Age Related Macular Degeneration Drug Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Age Related Macular Degeneration Drug Manufacturing Sites and Area Served Table 11. Manufacturers Age Related Macular Degeneration Drug Product Type Table 12. Global Age Related Macular Degeneration Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Age Related Macular Degeneration Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age Related Macular Degeneration Drug as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Age Related Macular Degeneration Drug Sales by Region (2016-2021) & (K Units) Table 16. Global Age Related Macular Degeneration Drug Sales Market Share by Region (2016-2021) Table 17. Global Age Related Macular Degeneration Drug Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Age Related Macular Degeneration Drug Sales by Country (2016-2021) & (K Units) Table 19. North America Age Related Macular Degeneration Drug Sales Market Share by Country (2016-2021) Table 20. North America Age Related Macular Degeneration Drug Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Age Related Macular Degeneration Drug Revenue Market Share by Country (2016-2021) Table 22. Europe Age Related Macular Degeneration Drug Sales by Country (2016-2021) & (K Units) Table 23. Europe Age Related Macular Degeneration Drug Sales Market Share by Country (2016-2021) Table 24. Europe Age Related Macular Degeneration Drug Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Age Related Macular Degeneration Drug Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Age Related Macular Degeneration Drug Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Age Related Macular Degeneration Drug Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Age Related Macular Degeneration Drug Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Age Related Macular Degeneration Drug Revenue Market Share by Region (2016-2021) Table 30. Latin America Age Related Macular Degeneration Drug Sales by Country (2016-2021) & (K Units) Table 31. Latin America Age Related Macular Degeneration Drug Sales Market Share by Country (2016-2021) Table 32. Latin America Age Related Macular Degeneration Drug Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Age Related Macular Degeneration Drug Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Age Related Macular Degeneration Drug Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Age Related Macular Degeneration Drug Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Age Related Macular Degeneration Drug Revenue Market Share by Country (2016-2021) Table 38. Global Age Related Macular Degeneration Drug Sales (K Units) by Type (2016-2021) Table 39. Global Age Related Macular Degeneration Drug Sales Market Share by Type (2016-2021) Table 40. Global Age Related Macular Degeneration Drug Revenue (Million US$) by Type (2016-2021) Table 41. Global Age Related Macular Degeneration Drug Revenue Share by Type (2016-2021) Table 42. Global Age Related Macular Degeneration Drug Price (USD/Unit) by Type (2016-2021) Table 43. Global Age Related Macular Degeneration Drug Sales (K Units) by Application (2016-2021) Table 44. Global Age Related Macular Degeneration Drug Sales Market Share by Application (2016-2021) Table 45. Global Age Related Macular Degeneration Drug Revenue (Million US$) by Application (2016-2021) Table 46. Global Age Related Macular Degeneration Drug Revenue Share by Application (2016-2021) Table 47. Global Age Related Macular Degeneration Drug Price (USD/Unit) by Application (2016-2021) Table 48. Regeneron Pharmaceuticals Corporation Information Table 49. Regeneron Pharmaceuticals Description and Business Overview Table 50. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product Table 52. Regeneron Pharmaceuticals Recent Developments/Updates Table 53. Bayer HealthCare Corporation Information Table 54. Bayer HealthCare Description and Business Overview Table 55. Bayer HealthCare Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Bayer HealthCare Age Related Macular Degeneration Drug Product Table 57. Bayer HealthCare Recent Developments/Updates Table 58. Novartis Corporation Information Table 59. Novartis Description and Business Overview Table 60. Novartis Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Novartis Age Related Macular Degeneration Drug Product Table 62. Novartis Recent Developments/Updates Table 63. Roche Corporation Information Table 64. Roche Description and Business Overview Table 65. Roche Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Roche Age Related Macular Degeneration Drug Product Table 67. Roche Recent Developments/Updates Table 68. Kanghong Pharma Corporation Information Table 69. Kanghong Pharma Description and Business Overview Table 70. Kanghong Pharma Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Kanghong Pharma Age Related Macular Degeneration Drug Product Table 72. Kanghong Pharma Recent Developments/Updates Table 73. Production Base and Market Concentration Rate of Raw Material Table 74. Key Suppliers of Raw Materials Table 75. Age Related Macular Degeneration Drug Distributors List Table 76. Age Related Macular Degeneration Drug Customers List Table 77. Age Related Macular Degeneration Drug Market Trends Table 78. Age Related Macular Degeneration Drug Growth Drivers Table 79. Age Related Macular Degeneration Drug Market Restraints Table 80. Global Age Related Macular Degeneration Drug Sales Forecast by Type (2022-2027) & (K Units) Table 81. Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Type (2022-2027) Table 82. Global Age Related Macular Degeneration Drug Revenue Forecast by Type (2022-2027) & (US$ Million) Table 83. Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Type (2022-2027) Table 84. Global Age Related Macular Degeneration Drug Sales Forecast by Application (2022-2027) & (K Units) Table 85. Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Application (2022-2027) Table 86. Global Age Related Macular Degeneration Drug Revenue Forecast by Application (2022-2027) & (US$ Million) Table 87. Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Application (2022-2027) Table 88. Global Age Related Macular Degeneration Drug Sales Forecast by Region (2022-2027) & (K Units) Table 89. Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Region (2022-2027) Table 90. Global Age Related Macular Degeneration Drug Revenue Forecast by Region (2022-2027) & (US$ Million) Table 91. Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Region (2022-2027) Table 92. Research Programs/Design for This Report Table 93. Key Data Information from Secondary Sources Table 94. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Age Related Macular Degeneration Drug Figure 2. Global Age Related Macular Degeneration Drug Market Share by Type in 2020 & 2027 Figure 3. Lucentis Product Picture Figure 4. Eylea Product Picture Figure 5. Avastin Product Picture Figure 6. Other Product Picture Figure 7. Global Age Related Macular Degeneration Drug Market Share by Application in 2020 & 2027 Figure 8. Hospitals Figure 9. Clinics Figure 10. Other Figure 11. Global Age Related Macular Degeneration Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Age Related Macular Degeneration Drug Market Size 2016-2027 (US$ Million) Figure 13. Global Age Related Macular Degeneration Drug Sales 2016-2027 (K Units) Figure 14. Global Age Related Macular Degeneration Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 15. Age Related Macular Degeneration Drug Sales Share by Manufacturers in 2020 Figure 16. Global Age Related Macular Degeneration Drug Revenue Share by Manufacturers in 2020 Figure 17. The Global 5 and 10 Largest Age Related Macular Degeneration Drug Players: Market Share by Revenue in 2020 Figure 18. Age Related Macular Degeneration Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 19. Global Age Related Macular Degeneration Drug Sales Market Share by Region (2016-2021) Figure 20. Global Age Related Macular Degeneration Drug Sales Market Share by Region in 2020 Figure 21. Global Age Related Macular Degeneration Drug Revenue Market Share by Region (2016-2021) Figure 22. Global Age Related Macular Degeneration Drug Revenue Market Share by Region in 2020 Figure 23. U.S. Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Canada Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Germany Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. France Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. U.K. Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Italy Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Russia Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. China Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Japan Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. South Korea Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. India Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Australia Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Taiwan Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Indonesia Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Thailand Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Malaysia Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Philippines Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Vietnam Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Mexico Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Brazil Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Argentina Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Turkey Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Saudi Arabia Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. U.A.E Age Related Macular Degeneration Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Sales Market Share of Age Related Macular Degeneration Drug by Type (2016-2021) Figure 48. Sales Market Share of Age Related Macular Degeneration Drug by Application (2016-2021) Figure 49. Sales Market Share of Age Related Macular Degeneration Drug by Application in 2020 Figure 50. Revenue Share of Age Related Macular Degeneration Drug by Application (2016-2021) Figure 51. Revenue Share of Age Related Macular Degeneration Drug by Application in 2020 Figure 52. Manufacturing Cost Structure of Age Related Macular Degeneration Drug Figure 53. Manufacturing Process Analysis of Age Related Macular Degeneration Drug Figure 54. Age Related Macular Degeneration Drug Industrial Chain Analysis Figure 55. Channels of Distribution Figure 56. Distributors Profiles Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

Regeneron Pharmaceuticals Bayer HealthCare Novartis Roche Kanghong Pharma